Jan Werner
MD, Clinician-Scientist. Neurology @UKKoeln - @UniCologne. Research focus on Neuro-Oncology, imaging and amino acid PET. Postdoc @MedUniWien
- 📃Just published in JNM: our recent study showing the clinical value of FET PET to identify early response to Regorafenib in patients with #glioma. 🔗: jnm.snmjournals.org/content/earl... Thanks to @galldiks.bsky.social, @ph-lohmann.bsky.social and co-authors. #aminoacidPET #braintumor
- 🚨 Today at #SNO2025 don’t miss the ASNO-EANO-SNO young investigator debates at 2:45 PM. @neuroonc.bsky.social @eanoassociation.bsky.social #ArtificialIntelligence #NeuroOncology @mjlimfat.bsky.social @spyridonbakas.bsky.social @ph-lohmann.bsky.social
- Start of the Educational Day of #SNO2025 and WFNOS2025. Welcoming by @mjlimfat.bsky.social. Looking forward to an inspiring conference in Honolulu. @neuroonc.bsky.social @eanoassociation.bsky.social
- Reposted by Jan WernerAwarded as best clinical science poster at #EANO2025 and now published online: "Clinical potential of [18F]FET PET in patients with circumscribed astrocytic glioma" by @jmwerner.bsky.social and colleagues. 👉 link.springer.com/article/10.1... #NuclearMedicine #Glioma #NeuroOncology #PETImaging
- Reposted by Jan WernerOutstanding oral presentation at #EANO2025 in Prague, now published in #NeuroOncology: the Multicenter Randomized Phase II Study of R-MPV-A #Chemoimmunotherapy With or Without Low-Dose Whole-Brain #Radiotherapy for Newly-Diagnosed Primary... by Antonio Omuro & colleagues. 👉 doi.org/10.1093/neuo...
- Reposted by Jan WernerTwo studies led by former #EANO President Matthias Preusser demonstrate the activity of HER3-DXd in patients with brain metastases from breast and lung cancer. Just published back-to-back in @thelancetoncol.bsky.social: 👉 breast cancer: bit.ly/4oEN1T2 👉 lung cancer: bit.ly/3LarqUf #TUXEDO3
- Happy to provide an overview of modern PET imaging in Neuro-Oncology at the joint EANO-EANM session #EANO2025. Use the RANO/EANO recommendations in clinical practice and apply/evaluate PET RANO 1.0 and PET RANO BM 1.0 @eanoassociation.bsky.social @galldiks.bsky.social @nathaliealbert.bsky.social
- Fully automated evaluation of FET PET in brain tumors presented at #EANO2025. Multicenter effort with validation of >1800 PET scans comparing automated workflow with manual evaluations. @ph-lohmann.bsky.social @fz-juelich.de @eanoassociation.bsky.social
- @mjlimfat.bsky.social closes the educational day at #EANO2025 with remarks and guidance on Pregnancy and Fertility Preservation in patients with brain tumors. @eanoassociation.bsky.social
- Reposted by Jan Werner💡Only a few seats left for the EANO Tumor Board 2025, taking place on October 15 in Prague. Join us for interactive case-based discussions and expert insights. Registration is free for EANO members. Please register by October 3. Learn more: www.eano.eu/eanomeetings...
- Reposted by Jan Werner🧠 The phase 1/2 N2M2 umbrella trial lead by former EANO president @wickwolfgang.bsky.social has just been published in Nature Medicine 🔗 www.nature.com/articles/s41... #NeuroOncology #EANOessentials #BrainTumors #CancerResearch
- Reposted by Jan Werner🧠 Just published in Neuro-Oncology: A comprehensive consensus review by @neuroonc.bsky.social and EANO on current management and future directions in adult #Glioblastoma care. Explore key recommendations and research priorities. 🔗 academic.oup.com/neuro-oncolo... #NeuroOncology
- Reposted by Jan Werner👉 An article discussing nerve-to-cancer transfer of mitochondria during cancer metastasis is now available in @nature.com 🔗 www.nature.com/articles/s41... #CancerResearch #BrainMetastases #NeuroOncology #EANOessentials #Nature #medsky
- Reposted by Jan Werner📣 New journal launch! Neuro-Oncology Pediatrics is live — an open-access journal advancing global research and care for children & young adults with brain tumors. A joint EANO & @neuroonc.bsky.social initiative. 🔗 Read more: www.eano.eu/about/news/n... #NeuroOncology @oxfordacademic.bsky.social
- Reposted by Jan Werner[This post could not be retrieved]
- Reposted by Jan WernerScientists are closing in on the ability to apply genome editing to a formidable new target: the human brain. go.nature.com/3HCKJUy
- Reposted by Jan Werner🧠 What is #ATTRACT – and how could it improve #glioblastoma care? This video (🇩🇪 with 🇬🇧 subs) explains how we test 28 drugs on tumor cells & personalize therapy. Made by @lbg.ac.at w/ Anna Berghoff (ATTRACT Head), @mj-mair.bsky.social (Deputy Head) & Matthias Preusser (Mentor) 🚀 youtu.be/NfxxMZ_xmF4
- Reposted by Jan Werner🧠 Just published in @thelancetoncol.bsky.social: Updated RANO and EANO recommendations on the clinical use of PET imaging in gliomas. 🔗 Read more: www.thelancet.com/journals/lan... #NeuroOncology #Glioma #PETimaging #EANO #RANO #BrainTumor #LancetOncology
- Happy to share our collaborative Point/Counterpoint article on upfront #BRAF inhibition for adult high-grade #gliomas - a summary of the first joint SNO/EANO Young Investigators debate at #SNO2024. @marjoleingeurts.bsky.social @mjlimfat.bsky.social doi.org/10.1093/neuo...
- Reposted by Jan Werner"43% of the global burden of disease is neurological, a concerningly high number." On #WorldBrainDay, a new letter—Brain health for all ages: a global call to action ➡️ tinyurl.com/yjvtunj3
- Reposted by Jan WernerA recent publication in Journal of Clinical Oncology covers stereotactic radiosurgery in small cell lung cancer patients with 1–10 brain metastases, from a multi-institutional phase II prospective trial. 🔗 ascopubs.org/doi/10.1200/... #NeuroOncology #Glioma #BrainMetastases #EANOessentials #medsky
- Reposted by Jan Werner🌍 Full text access to the PET RANO BM 1.0 criteria for response assessment of brain metastases based on amino acid PET imaging: rdcu.be/ew8m0.
- Reposted by Jan Werner👉 Recently published in Clinical Cancer Research: A population-level real-world analysis and single-center validation of melanoma brain metastasis epidemiology following dual-agent immunotherapy 🔗 doi.org/10.1158/1078... #EANOessentials #NeuroOncology #BrainMetastases #brainMets #medsky
- Reposted by Jan Werner🧠 Recently published in Cancer Cell: Genetic modeling of ELP1-associated Sonic hedgehog medulloblastoma identifies MDM2 as a selective therapeutic target. Read the full article: www.cell.com/cancer-cell/... #EANOessentials #NeuroOncology #MalignantBrainTumor #medulloblastoma #medsky
- Reposted by Jan WernerA new article addressing clinical trial enrollment of glioma patients using supervised machine learning is now available in Science Advances. 📖 Read the full article: www.science.org/doi/10.1126/... #EANOessentials #NeuroOncology #Glioma #MachineLearning #medsky
- Reposted by Jan Werner🧠 Recently published in Nature Cancer: Cellular hierarchies of embryonal tumors with multilayered rosettes are shaped by oncogenic microRNAs and receptor–ligand interactions Learn more: www.nature.com/articles/s43... #EANOessentials #NeuroOncology #MalignantBrainTumor #PediatricBrainCancer #medsky
- Reposted by Jan WernerRecently published in Neuro-Oncology: Clinical, molecular and radiological predictors of prognosis in newly diagnosed astrocytoma, IDH-mutant, WHO grade 4. 🔗 doi.org/10.1093/neuo... #EANOessentials #NeuroOncology #glioma #medsky
- Reposted by Jan Werner🧠 A recent EORTC - European Organisation for Research and Treatment of Cancer study highlights the availability and use of amino acid PET in patients with brain tumors. 🔗 Read the full story: link.springer.com/article/10.1... #EANOessentials #NeuroOncology #MalignantBrainTumor #PETimaging #medsky
- Reposted by Jan Werner🧠 New EORTC survey shows PET imaging is widely available and used across European brain tumour centres. With data from 103 centres in 20 countries, the findings support PET-based endpoints in future trials. 🔗 Find out more: www.eortc.org/blog/2025/07... #EORTCbrain #PETImaging
- Reposted by Jan Werner🧬 A new article on ultra-rapid tumor diagnosis is now available in Neuro-Oncology: "ROBIN: A unified nanopore-based assay integrating intraoperative methylome classification and next ..." 🔗 Full access: doi.org/10.1093/neuo... #EANOessentials #NeuroOncology #MalignantBrainTumor #methylomics #medsky
- Reposted by Jan WernerLive from #ASCO25 in Chicago: presentation of latest results on HER3-DXd efficacy and safety in patients with leptomeningeal metastatic disease of solid tumors - with simultaneous publication in Nature Medicine. Learn more: doi.org/10.1038/s415... #NeuroOncology
- Reposted by Jan Werner#50ScientistsThatInspire 🧪 A collection created by @cellpress.bsky.social for #Cell50 🎉 Including inspiring #scientists and committed #advocates in their communities 🙌 In this 🧵 I'll share some of the interviews - including this Q&A we did 👇 Its an honor to be part of this incredible list 🙏 🙏
- Reposted by Jan WernerRecently published in Neuro-Oncology: Charting the Single-Cell and Spatial Landscape of IDH-Wildtype Glioblastoma with GBmap. Read full article 👉 doi.org/10.1093/neuo... #EANOessentials #Neuro-Oncology #glioma #glioblastoma
- Reposted by Jan Werner💪Neuro-Oncology Pediatrics – a new open access journal by EANO & @neuroonc.bsky.social for the global #pediatric & AYA #NeuroOncology community. Now open for submissions! 🔗 academic.oup.com/neuro-onc-peds Editor-in-Chief: S. Mueller Executive Editors: M. A. Roldán (EANO), @bandolab.bsky.social (SNO)
- Reposted by Jan Werner🧠 Join the next #EANOYoungsters Journal Club on June 5, 16:30–17:30 CEST! Discussing: "Rapid molecular profiling of CNS tumors" www.nature.com/articles/s41... (Patel et al., Nat Med 2025) 📍Free & open to all EANO members 🔗 www.eano.eu #NeuroOncology #BrainTumors #JournalClub
- Interested in telomere maintenance? 📢 Open PhD position in experimental oncology! Please distribute. jobs-uk-koeln.onlyfy.jobs/job/sypg9i9n...
- Reposted by Jan Werner🤩 The stage is set for day 2 of #NMN2025! Getting ready for another day full of cutting edge science on molecular imaging and theranostics of gliomas, brain metastases and meningioms. 🧠 www.nmn-society.org/program/
- Excellent debates and talks in Vienna during the second day of #NMN2025 meeting. Already looking forward to next year! @nmnsymposium.bsky.social @galldiks.bsky.social @nathaliealbert.bsky.social @marjoleingeurts.bsky.social
- Reposted by Jan WernerLive from @nmnsymposium.bsky.social in Vienna: introduction of first RANO criteria for response assessment of brain metastases based on amino acid PET - with simultaneous publication in Nature Medicine. Learn more: www.nature.com/articles/s41... #braincancer #PETimaging
- Reposted by Jan Werner🧠Recently published in Neuro-Oncology: Multimodal glioma immunotherapy combining TLR9-targeted STAT3 antisense oligodeoxynucleotides with PD1 immune checkpoint blockade. Full article 👉 doi.org/10.1093/neuo... #EANOessentails #NeuroOncology #immunotherapy #glioma
- Reposted by Jan Werner🧬 Neuro-Oncology recently featured a study on germline analysis of an international cohort of pediatric diffuse midline glioma patients. 🔗 academic.oup.com/neuro-oncolo... #EANOessentials #DIPG #Pediatric #Glioma #NeuroOncology @neuroonc.bsky.social
- Reposted by Jan Werner🧬A recent study published in @jama.com explores the role of Chromosome 1p loss and 1q gain for improved grading of meningiomas.🔍 Learn more: jamanetwork.com/journals/jam... #EANOessentials #NeuroOncology #Meningioma #Neurosurgery
- Reposted by Jan Werner🧠 A new article on the characteristics, outcomes, and prognostic factors of young patients with WHO grade 3 oligodendrogliomas (IDH-mutant and 1p/19q codeleted) can be found in Cancer. Full article👉 acsjournals.onlinelibrary.wiley.com/doi/10.1002/... #EANOessentials #NeuroOncology #Oligodendroglioma
- Reposted by Jan WernerThis research examines the single-cell and spatial genomic landscape of non-small cell lung cancer (#NSCLC) brain metastases. 🔗 Read the full article in Nature Medicine 👉 rdcu.be/eh8y7 #EANOessentials #NeuroOncology #BrainMetastases #btsm
- Reposted by Jan WernerAn External, Independent Validation of an O-(2-[18F]Fluoroethyl)-l-Tyrosine PET Automatic Segmentation Network on a Single-Center, Prospective Dataset of Patients with Glioblastoma. jnm.snmjournals.org/content/earl...
- Reposted by Jan Werner🧬 This research examines the single-cell atlas of endothelial & mural cells across primary & metastatic brain tumors. Published in Immunity. 🔗 www.cell.com/immunity/ful... #Glioma #NeuroOncology #EANOessentials #BrainMetastasis #TumorMicroenvironment
- Reposted by Jan Werner🧠 A recent publication in @naturemedicine.bsky.social covers rapid brain tumor classification from sparse epigenomic data. This #OpenAccess study highlights a novel approach to tumor profiling and diagnostics.🔗Read more: www.nature.com/articles/s41... #NeuroOncology #Neurosurgery #EANOessentials
- Reposted by Jan WernerThis study explores the impact of the OLIG2 inhibitor CT-179 in suppressing recurrence in Sonic Hedgehog subgroup medulloblastoma. Now available open access in @nature.com! 🔗 Learn more: www.nature.com/articles/s41... #EANOessentials #NeuroOncology #Medulloblastoma #OpenAccess #btsm
- Reposted by Jan Werner🧠 A recent publication in @nature.com Scientific Reports covers an effective MRI perfusion threshold-based workflow to triage additional 18F-FET PET in posttreatment high-grade glioma.🔓🔗Read more: nature.com/articles/s41... #EANOessentials #NeuroOncology #Glioma #BrainTumors #PET
- Reposted by Jan Werner🔬A new open access article on GABAergic neuron-to-glioma synapses in diffuse midline gliomas is now available in @nature.com ! Read it here 👉https://www.nature.com/articles/s41586-024-08579-3 #EANOessentials #NeuroOncology #BrainTumors #OpenAccess #btsm
- Reposted by Jan WernerRecently published in @science.org: A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma. Learn more 👉https://science.org/doi/10.1126/scitranslmed.adn6274 #EANOessentials #NeuroOncology #Glioma #btsm
- Reposted by Jan Werner🌍 #EANO2024 in Glasgow gathered 1,200+ global participants, featuring cutting-edge research and insights to shape the future of #NeuroOncology. Be part of this community at #EANO2025! Watch our highlight video & renew your membership today for many benefits! bit.ly/4i6djdF See you in Prague! 👋
- Reposted by Jan Werner🔬✨ Be a part of #EANO2025! Submit your abstract now and present your research as an oral presentation or poster at the big event in Prague. We can't wait to see your contributions! Click here for more information: www.eano.eu/eano2025/abs... #NeuroOncology #neurosurgery #cancernurse
- Reposted by Jan Werner#Cancer research needs #neuroscience and neuroscientists. Sharing some thoughts on #CancerNeuroscience, together with Frank Winkler. www.nature.com/articles/s41...
- Reposted by Jan Werner💥 PET imaging of CNS tumors: must have or nice to have? Join the debate at the #NMN2025 Symposium on May 09/10th in Vienna and register today: www.nmn-society.org/registration/!
- Reposted by Jan WernerTherapeutic potential of FAPI RLT in oncology: A systematic review. www.thno.org/v15p4084.htm
- Reposted by Jan Werner📅 Mark your calendars! Abstract submissions for #EANO2025 are due April 30. Don’t miss your chance to showcase your #NeuroOncology research this October! 🌍✨ 🔬 Submit now: www.eano.eu/eano2025/abs... #btsm #neurosurgery #glioma #RadOnc #BrainCancer #cancernurse #AHP
- Reposted by Jan Werner📣 Still time to register! Join the 3rd Annual Highlights of EANO/SNO 2024 webinar and hear key insights from #EANO2024 (Glasgow) and #SNO2024 (Boston). 🗓 March 7, 2025 | ⏰ 6:30 PM CET | 12:30 PM ET 🔗 Register now: eano.eu/eanowebinar/ @neuroonc.bsky.social
- Reposted by Jan WernerRecently published in @cellpress.bsky.social: Microglial reprogramming enhances antitumor immunity and immunotherapy response in melanoma brain metastases 👉 bit.ly/3XmWyD8 #EANOessentials #BrainMetastases #NeuroOncology